-+ 0.00%
-+ 0.00%
-+ 0.00%

Kimberly Clark (KMB) Could Be 11% Undervalued On Dividends And Kenvue Risk

Simply Wall St·11/19/2026 05:10:26
Listen to the news

Kimberly-Clark (KMB) is back in focus after its board reaffirmed a regular quarterly dividend of $1.28 per share, extending a 92 year payment streak and 54 consecutive years of increases.

Recent action has been steady rather than dramatic, with Kimberly-Clark’s share price up 5.76% year to date at US$107.24 and a 1-year total shareholder return of 10.12% pointing to modest momentum, although the 5-year total shareholder return is slightly negative.

The quarterly earnings update on 5 November, which showed higher net income and earnings per share alongside relatively flat sales, helped underpin that move. The reaffirmed dividend policy now reinforces how investors are weighing income stability against integration risks tied to the Kenvue acquisition and the associated debt load.

Scan beyond Kimberly-Clark to compare its long dividend run and acquisition risks with a hand-picked 30 resilient stocks with low risk scores that aims for resilience first.

Kimberly-Clark’s share price has climbed, yet analyst targets and intrinsic value estimates point to a much wider upside band. Is the recent move already fair, or is the market still pricing in caution?

Most Popular Narrative: 10% Undervalued

On the analyst consensus Narrative on Simply Wall St, Kimberly-Clark’s fair value of about $118.67 sits above the last close at $107.24, which frames the current price as a discount while still factoring in execution and balance sheet risks.

Strategic refocus on higher growth, higher margin Personal Care and health oriented categories is advancing through the Arbex joint venture and the planned Kenvue acquisition. Together, these initiatives are expected to reshape Kimberly-Clark’s portfolio mix and cost base in a way that can support higher long term gross margin and EPS.

See why 107 investors see Kimberly-Clark as 10% undervalued.

Result: Fair Value of $118.67 (UNDERVALUED)

Still, the narrative frays quickly if organic growth continues to lag category trends or if higher input, freight and tariff costs squeeze the margin story analysts are using.

Find out about the key risks to this Kimberly-Clark narrative.

Another View: Kimberly-Clark Looks Expensive On P/E

The DCF narrative points to Kimberly-Clark as undervalued, yet the market multiple tells a tougher story. The stock trades on a P/E of 37.7x, above both the peer average of 29.2x and the Global Household Products group at 17.7x, and above the fair ratio of 30.9x. Is the premium a cushion or a source of downside risk if expectations reset?

See what the numbers say about this price in more detail, starting with our valuation breakdown, then cross check it against your own assumptions before acting. See what the numbers say about this price — find out in our valuation breakdown.

Put the current P/E in context against sector and index levels visually to sense check how much optimism is already in the price.

NasdaqGS:KMB P/E Ratio as at Nov 2026
NasdaqGS:KMB P/E Ratio as at Nov 2026

Next Steps

Curious whether the mixed signals around Kimberly-Clark add up to opportunity or just extra risk on your watchlist? Move quickly, pull up the underlying data, and pressure test the bullish and cautious arguments side by side with the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Kimberly-Clark?

If Kimberly-Clark has your attention, do not stop there. Use fresh data and clear filters to surface other opportunities that fit your style and risk tolerance.